Knowledge-augmented Graph Machine Learning for Drug Discovery: A Survey

• URL: http://arxiv.org/abs/2302.08261v3
• Date: Wed, 24 Jul 2024 07:26:59 GMT
• Title: Knowledge-augmented Graph Machine Learning for Drug Discovery: A Survey
• Authors: Zhiqiang Zhong, Anastasia Barkova, Davide Mottin,
• Abstract summary: Graph Machine Learning (GML) has gained considerable attention for its exceptional ability to model graph-structured biomedical data. Recent studies have proposed integrating external biomedical knowledge into the GML pipeline to realise more precise and interpretable drug discovery.
• Score: 6.288056740658763
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: The integration of Artificial Intelligence (AI) into the field of drug discovery has been a growing area of interdisciplinary scientific research. However, conventional AI models are heavily limited in handling complex biomedical structures (such as 2D or 3D protein and molecule structures) and providing interpretations for outputs, which hinders their practical application. As of late, Graph Machine Learning (GML) has gained considerable attention for its exceptional ability to model graph-structured biomedical data and investigate their properties and functional relationships. Despite extensive efforts, GML methods still suffer from several deficiencies, such as the limited ability to handle supervision sparsity and provide interpretability in learning and inference processes, and their ineffectiveness in utilising relevant domain knowledge. In response, recent studies have proposed integrating external biomedical knowledge into the GML pipeline to realise more precise and interpretable drug discovery with limited training instances. However, a systematic definition for this burgeoning research direction is yet to be established. This survey presents a comprehensive overview of long-standing drug discovery principles, provides the foundational concepts and cutting-edge techniques for graph-structured data and knowledge databases, and formally summarises Knowledge-augmented Graph Machine Learning (KaGML) for drug discovery. we propose a thorough review of related KaGML works, collected following a carefully designed search methodology, and organise them into four categories following a novel-defined taxonomy. To facilitate research in this promptly emerging field, we also share collected practical resources that are valuable for intelligent drug discovery and provide an in-depth discussion of the potential avenues for future advancements.

Related papers

• The Role of Graph Topology in the Performance of Biomedical Knowledge Graph Completion Models [3.1666540219908272]
  We conduct a comprehensive investigation into the properties of publicly available biomedical Knowledge Graphs. We establish links to the accuracy observed in real-world applications. We release all model predictions and a new suite of analysis tools.
  arXiv  Detail & Related papers  (2024-09-06T08:09:15Z)
• Explainable Biomedical Hypothesis Generation via Retrieval Augmented Generation enabled Large Language Models [46.05020842978823]
  Large Language Models (LLMs) have emerged as powerful tools to navigate this complex data landscape. RAGGED is a comprehensive workflow designed to support investigators with knowledge integration and hypothesis generation.
  arXiv  Detail & Related papers  (2024-07-17T07:44:18Z)
• Simplicity within biological complexity [0.0]
  We survey the literature and argue for the development of a comprehensive framework for embedding of multi-scale molecular network data. Network embedding methods map nodes to points in low-dimensional space, so that proximity in the learned space reflects the network's topology-function relationships. We propose to develop a general, comprehensive embedding framework for multi-omic network data, from models to efficient and scalable software implementation.
  arXiv  Detail & Related papers  (2024-05-15T13:32:45Z)
• Diversifying Knowledge Enhancement of Biomedical Language Models using Adapter Modules and Knowledge Graphs [54.223394825528665]
  We develop an approach that uses lightweight adapter modules to inject structured biomedical knowledge into pre-trained language models. We use two large KGs, the biomedical knowledge system UMLS and the novel biochemical OntoChem, with two prominent biomedical PLMs, PubMedBERT and BioLinkBERT. We show that our methodology leads to performance improvements in several instances while keeping requirements in computing power low.
  arXiv  Detail & Related papers  (2023-12-21T14:26:57Z)
• ProBio: A Protocol-guided Multimodal Dataset for Molecular Biology Lab [67.24684071577211]
  The challenge of replicating research results has posed a significant impediment to the field of molecular biology. We first curate a comprehensive multimodal dataset, named ProBio, as an initial step towards this objective. Next, we devise two challenging benchmarks, transparent solution tracking and multimodal action recognition, to emphasize the unique characteristics and difficulties associated with activity understanding in BioLab settings.
  arXiv  Detail & Related papers  (2023-11-01T14:44:01Z)
• ImDrug: A Benchmark for Deep Imbalanced Learning in AI-aided Drug Discovery [79.08833067391093]
  Real-world pharmaceutical datasets often exhibit highly imbalanced distribution. We introduce ImDrug, a benchmark with an open-source Python library which consists of 4 imbalance settings, 11 AI-ready datasets, 54 learning tasks and 16 baseline algorithms tailored for imbalanced learning. It provides an accessible and customizable testbed for problems and solutions spanning a broad spectrum of the drug discovery pipeline.
  arXiv  Detail & Related papers  (2022-09-16T13:35:57Z)
• Scientific Language Models for Biomedical Knowledge Base Completion: An Empirical Study [62.376800537374024]
  We study scientific LMs for KG completion, exploring whether we can tap into their latent knowledge to enhance biomedical link prediction. We integrate the LM-based models with KG embedding models, using a router method that learns to assign each input example to either type of model and provides a substantial boost in performance.
  arXiv  Detail & Related papers  (2021-06-17T17:55:33Z)
• A Review of Biomedical Datasets Relating to Drug Discovery: A Knowledge Graph Perspective [4.746544835197422]
  We aim to help guide machine learning and knowledge graph practitioners who are interested in applying new techniques to the drug discovery field. We detail publicly available primary data sources containing information suitable for use in constructing various drug discovery focused knowledge graphs.
  arXiv  Detail & Related papers  (2021-02-19T17:49:38Z)
• Utilising Graph Machine Learning within Drug Discovery and Development [19.21101749270075]
  Graph Machine Learning (GML) is receiving growing interest within the pharmaceutical and biotechnology industries for its ability to model biomolecular structures. Herein, we present a multidisciplinary academic-industrial review of the topic within the context of drug discovery and development. After introducing key terms and modelling approaches, we move chronologically through the drug development pipeline to identify and summarise work incorporating: target identification, design of small molecules and biologics, and drug repurposing.
  arXiv  Detail & Related papers  (2020-12-09T10:12:33Z)
• Machine Learning in Nano-Scale Biomedical Engineering [77.75587007080894]
  We review the existing research regarding the use of machine learning in nano-scale biomedical engineering. The main challenges that can be formulated as ML problems are classified into the three main categories. For each of the presented methodologies, special emphasis is given to its principles, applications, and limitations.
  arXiv  Detail & Related papers  (2020-08-05T15:45:54Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.